 |
|
|
|
Our mission is to extend and enhance human life by providing the highest-quality pharmaceutical and related health care products.
We are committed to ensuring health care professionals have access to the most innovative medicines and up-to-date information to help them better treat their patients. We’re investing significant resources in new compounds, including hundreds of millions of pounds in our biologics capabilities. We have a particularly robust group of potential medicines in development, including promising late-stage compounds for cancer, HIV/AIDS and immunological diseases.
We take our goal to be a health care leader of the future seriously and hold ourselves accountable to the highest standards of integrity, ethical behaviour and professionalism. In 2005, we announced a new policy on the disclosure of clinical trial information. We now disclose all results from Bristol-Myers Squibb-sponsored trials conducted in patients, regardless of outcome on a timely basis. Information on our latest trials can be viewed at: www.clinicalstudyresults.org and www.clinicaltrials.gov |
|
|
